DUBLIN (AP) — DUBLIN (AP) — Jazz Pharmaceuticals PLC (JAZZ) on Wednesday reported a loss of $14.6 million in its first quarter.
The Dublin-based company said it had a loss of 23 cents per share. Earnings, adjusted for amortization costs and stock option expense, were $2.68 per share.
The results did not meet Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $4.14 per share.
The drugmaker posted revenue of $902 million in the period, also falling short of Street forecasts. Ten analysts surveyed by Zacks expected $939 million.
Jazz expects full-year earnings in the range of $18.15 to $19.35 per share, with revenue in the range of $4 billion to $4.2 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on JAZZ at https://www.zacks.com/ap/JAZZ
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
